Healthcare Pharmaceutical Biotech

Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary

October 5, 2026 8:00 AM

Vicapsys Life Sciences, Inc. (OTC PINK:VICP) ("VICP" or the "Company") today announced that FutureBrand, the global brand consultancy behind the corporate identities of Sanofi, GSK and Merck, has onboarded the Company as a client through its Latin America practice and delivered a new corporate identity for Vicapsys Life Sciences and its wholly owned subsidiary, Stateline Distributors of Puerto Rico, Inc. ("Stateline"). The rollout of the new...

Read more

Hypha Labs Targets Disruptive Mushroom Active Ingredient Production

October 5, 2026 8:00 AM

The global functional mushroom market is estimated to reach $42.27 billion in 2026 and projected to grow to $95.95 billion by 2033, according to Grand View Research. Hypha Labs, Inc. is developing a disruptive biomanufacturing platform to address a critical challenge within this expanding industry: producing mushroom-derived active ingredients faster, more consistently, and at lower cost. Hypha Labs' Mushroom Accelerator™ platform is designed to...

Read more

Bristol Myers Squibb Deepens Commitment to Healthcare Professionals Through Champions in Care Movement

October 5, 2026 7:29 AM

Originally published by Bristol Myers Squibb Bristol Myers Squibb (NYSE:BMY) recently announced the expansion of Champions in Care, the company's initiative honoring healthcare professionals (HCPs), first launched in 2025. Now in its second year, the campaign builds on its inaugural effort that celebrated HCPs across therapeutic areas through digital, social and live engagement. This year's expansion introduces new opportunities for HCPs to...

Read more

Genflow Biosciences PLC Announces Presentation of Interim Results

October 5, 2026 2:40 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF), a biotechnology company developing gene therapies targeting the biology of ageing, announces that interim results from SLAB-VET-001 are being presented today at the Animal Longevity Summit (ALOS) in Toronto, Canada. SLAB-VET-001 is its controlled study of SIRT6c gene therapy in aged dogs. Highlights SLAB is a four-arm controlled blinded clinical trial conducted in 24 aged Beagles. It evaluates...

Read more

GLP1 Medication and GLP1 Pills Gain Ground as Weight-Management Options Expand

October 4, 2026 10:25 AM

For several years, much of the public conversation around GLP-1 treatment centered on injections. In 2026, however, oral semaglutide has made GLP1 pills part of the weight-management conversation alongside the GLP1 medication options that many consumers already associate with weekly shots. That change gives women another format to learn about-but it also adds another layer to a subject already crowded with drug names, brand names and terminology...

Read more

Synthesis Peptides Reviews 2026: Your Next Research Supplier? GHK-Cu Pricing, Volume Discounts, and COA Details

October 2, 2026 9:00 PM

Disclosures. This is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims are attributed to the brand and are not independently endorsed. Synthesis Peptides sells for laboratory research use only ("Not for human consumption, diagnostic, or therapeutic use," per the brand), to buyers 21 or older. Official website: synthesispeptides.co. Details reflect brand pages read in October 2026. This...

Read more

Jaguar Health Announces a Special Stock Dividend

October 2, 2026 8:35 PM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or "the Company") today announced that its Board of Directors has declared a special stock dividend (the "Special Stock Dividend") to holders of Jaguar Common Stock and certain outstanding warrants as of record on October 13, 2026. The Special Stock Dividend will consist of the Company's Series R Convertible Preferred Stock (the "Preferred Stock"). The CUSIP number for the Preferred Stock is 47010C847....

Read more

Loti Labs Peptides Reviews 2026: Looking for Your Next Research Supplier? Explore the Catalog, COA Access, and Quantity Pricing

October 2, 2026 8:15 PM

Disclaimers: This is a paid advertorial, and a commission is earned if you purchase through links in this article. Product claims are attributed to the brand and aren't independently endorsed. Loti Labs labels these materials for laboratory research use only; that label doesn't settle regulatory status, and this article doesn't recommend personal use. This content is promotional and intended to educate consumers about a commercially available...

Read more

Get Bars 7-OH Tablets Reviews 2026: What's in the Pack? Inside the Product Lines, Labels, and Lab Reports

October 2, 2026 8:15 PM

Advertorial notice: This is advertorial content, promotional in nature and intended for consumer education about a commercially available product. It contains no affiliate links, isn't medical advice, and doesn't recommend buying or using anything. Brand statements are the brand's own and haven't been independently verified. Brand website: getbars.co. Reviewed October 3, 2026. Get Bars Pricing, Shipping and Product Details Get Bars 7-OH Tablets...

Read more

Psychiatrist-Developed Siyan Stride Connects Daily Walking With Mental Wellbeing

October 2, 2026 1:30 PM

Siyan Clinical Corporation today introduced Siyan Stride, a walking and wellness app created by psychiatrist Dr. Anish S. Shah to help people build a routine they can sustain. The app brings daily activity and self-reported wellbeing together in one place, pairing personal walking goals with a brief daily check-in on body, energy and mood. Whether it is an older adult staying active, someone rebuilding a routine after a difficult period, or a...

Read more

CVS Health: After 30 Years, a Hepatitis C Treatment That Finally Worked

October 2, 2026 9:00 AM

Originally published on CVS Health Company Newsroom For more than 30 years, Mary lived with hepatitis C, uncertain whether she would ever be free of the disease. Then earlier this year, she received the news she had been waiting decades to hear. "Mary, the virus is gone. It's undetectable. You're cured." The call came from her physician, Rebecca Anastos-Wallen, MD, Chief Clinical Officer at Oak Street Health, and marked the end of a journey made...

Read more

Beyond Coding: Black Book Expands 2027 Mid-Revenue Cycle Categories Ahead of AHIMA26

October 2, 2026 7:00 AM

Black Book Research today announced an expanded mid-revenue-cycle category framework for 2027, addressing how artificial intelligence and coding innovations are changing the work performed between clinical documentation and reimbursement. The announcement comes ahead of AHIMA26, October 4-6 in San Antonio. The expanded framework brings established mid-cycle categories together with more specialized technology and service segments. Its central...

Read more

American Kratom Association Urges Mississippi Attorney General Fitch to Amend Kratom Ban Recommendation

October 1, 2026 11:52 PM

The American Kratom Association today sent a letter to Mississippi Attorney General Lynn Fitch urging her to amend her call for a statewide ban on all kratom and instead support legislation specifically prohibiting dangerous synthetic and chemically manipulated opioid products. American Kratom Association Urges Mississippi Attorney General Fitch to Amend Kratom Ban Recommendation / Source: American Kratom Association (AKA) (EZ Newswire) The...

Read more

Applied AI LLC Releases New Research on the AI-Native Future of Consumer Intelligence

October 1, 2026 7:10 PM

Applied AI today announced the release of The AI-Native Consumer Intelligence Enterprise 2027: From Verified Behavioral Data to Autonomous Decisions, a new research paper examining how artificial intelligence is reshaping consumer intelligence, data science and the infrastructure organizations use to understand and act on consumer behavior. Authored under the direction of Vasyl Harasymiv, Founder, the report moves beyond conventional discussions...

Read more

Medicure Announces Grant of Stock Options

October 1, 2026 6:35 PM

Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, today announced the granting of stock options (the "Options") to certain directors, officers, employees and consultants of the Company to purchase a total of 150,000 common shares of the Company at a price of $2.88...

Read more

Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion

October 1, 2026 3:58 PM

Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided an overview of its brand portfolio and the global markets it addresses. The portfolio comprises more than 15 proprietary brands and product lines and 10 branded generics across five product categories, sold in more than 40 countries through pharmacies, hospitals, retail chains and e-commerce. It is...

Read more

Hillary M. Wright Joins the Theralogix Medical Advisory Board

October 1, 2026 3:30 PM

Theralogix, a national leader in the supplement industry, announces the addition of Hillary M. Wright, MEd, RDN, LDN, to its Medical Advisory Board. She brings more than three decades of experience as a registered dietitian, educator, and author, with expertise in women's health, fertility, and metabolic health. Hillary Wright serves as Director of Nutrition at The Wellness Center at Boston IVF, where she specializes in nutrition and women's...

Read more

Weber West Eye Care Adds Tixel Technology to Expand Dry Eye Treatment Options

October 1, 2026 1:52 PM

Serving patients of all age groups, Weber West Eye Care has been providing eye care to the tri-state area for more than 10 years. The practice has extensive experience in the management and care of ocular conditions, including dry eye, glaucoma, cataracts, macular degeneration, and diabetes. As part of its commitment to providing patients with access to advanced treatment options, Weber West Eye Care has added Tixel technology to its services....

Read more

California Care Recovery Launches Quarterly Scholarship Covering Full Cost of Addiction Treatment - Including Travel - at No Cost

October 1, 2026 12:00 PM

California Care Recovery, a nationally recognized addiction treatment center based in Orange County, California, today announced the launch of the Care Forward Scholarship - a first-of-its-kind quarterly program that covers the full cost of addiction treatment, including roundtrip travel, for one individual who cannot afford care. Valued at up to $60,000 per recipient, the scholarship covers clinical assessment, up to 30 days of treatment, and...

Read more

Enyrgy Appoints Paul Sanchez to Its Financial Advisory Council

October 1, 2026 12:00 PM

Enyrgy Inc. has appointed Paul Sanchez to the Company's Financial Advisory Council, adding capital markets and family office depth and experience to the Council. Mr. Sanchez will advise on financial planning and capital strategy. He joins Enyrgy, a company carrying a product return rate under 1 percent against an industry average of 5 to 10 percent, on a user base built without paid advertising. Mr. Sanchez is a partner at Terra Rossa Family...

Read more